Helps maintain lean muscle while burning fat
Data were obtained from Summaries of Product Characteristics T2DM type 2 diabetes mellitus, OB obesity, OW overweight, SC subcutaneous, OS oral use, GLP-1 glucagon-like peptide 1, GIP gastric inhibitory polypeptide, DPP4 dipeptidyl peptidase 4, NEP enzyme neutral endopeptidase GLP-1 RAs mimic the action of the endogenous incretin hormone GLP-1 by activating GLP-1 receptors in pancreatic -cells
Jessica Walls (5-month program) Total Weight Lost: 35.5 lbs (162.3 lbs to 126.8 lbs) Muscle Lost: 3.5 lbs (94.4% retention) Body Fat Reduction: 31.6% to 16.8% Daniel Lindberg (6-month program) Total Weight Lost: 50.1 lbs (247.8 lbs to 197.7 lbs) Muscle Lost: 9.3 lbs (91.7% retention) Body Fat Reduction: 25.2% to 8.9% Both Daniel and Jessica achieved exceptional outcomes, maintaining over 90% of their muscle mass, far surpassing typical GLP-1 results
10.2337/db06-1491 15 CarvalhoM
I mean, I dont want to pick a date, but again its one thing to try to disrupt an industry and say, Hey, pay a little bit more because its for the greater good. Thats not what were asking
Ozempic and similar weight loss drugs, known as GLP-1s, make people less hungry, but they don't seem to stop them from going out to eat
